CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: Caffeine for Hypoxic-Ischemic Encephalopathy [Phase 1]
Summary
A Phase 1 clinical trial evaluating caffeine for hypoxic-ischemic encephalopathy has completed enrollment and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of North Carolina, Chapel Hill | Conditions: Hypoxic-Ischemic Encephalopathy | Phase 1 | Status: COMPLETED | Results posted: 2024-09-19